Table 2.

Study oversight

Role of study	Name	Institution
Principal investigator Steering Committee	Shinichiro Ueda, MD, PhD	Department of Pharmacology and Therapeutics, University of the Ryukyus
Co-principal investigator Steering Committee	Takeshi Morimoto, MD, PhD, MPH	Department of Clinical Epidemiology, Hyogo College of Medicine
Steering Committee	Osamu Arasaki, MD	Department of Cardiology, Tomishiro Central Hospital
Steering Committee	Koichi Node, MD, PhD	Department of Cardiovascular Medicine, Saga University
Steering Committee	Michio Shimabukuro, MD, PhD	Department of Diabetes, Endocrinology and Metabolism, Fukushima Medical University
Steering Committee	Takashi Nomiyama, MD, PhD	Department of Endocrinology and Diabetes Mellitus, Fukuoka university,
Event Adjudication Committee	Akihiro Tokushige, MD, PhD	Department of Pharmacology and Therapeutics, University of the Ryukyus
Event Adjudication Committee	Masahiro Natsuaki, MD, PhD	Department of Cardiovascular Medicine, Saga University
Event Adjudication Committee	Tomohiro Asahi, MD, PhD	Department of Cardiology, Naha City Hospital
Data Safety Monitoring Board	Keijiro Saku, MD, PhD	General Medical Research Center, Fukuoka University
Data Safety Monitoring Board	Tetsunori Saikawa, MD, PhD	Okubo Hospital
Data Safety Monitoring Board	Kohei Kaku, MD, PhD	Department of General Internal Medicine 1, Kawasaki Medical School
Study statistician	Mio Sakuma, MD, PhD, MPH	Institute for Clinical Effectiveness
Study statistician	Takeshi Morimoto, MD, PhD, MPH	Department of Clinical Epidemiology, Hyogo College of Medicine
Study secretariat	–	Department of Pharmacology and Therapeutics, University of the Ryukyus
Project management	–	Institute for Clinical Effectiveness
Data management	–	Institute for Clinical Effectiveness
Study advisor	Hisao Ogawa, MD, PhD	National Cerebral and Cardiovascular Center